These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development of Orodispersible Tablets of Candesartan Cilexetil- β -cyclodextrin Complex. Sravya M; Deveswaran R; Bharath S; Basavaraj BV; Madhavan V J Pharm (Cairo); 2013; 2013():583536. PubMed ID: 26555987 [TBL] [Abstract][Full Text] [Related]
4. Manufacturing and Assessing the New Orally Disintegrating Tablets, Containing Nimodipine-hydroxypropyl-β-cyclodextrin and Nimodipine-methyl-β-cyclodextrin Inclusion Complexes. Novac M; Musuc AM; Ozon EA; Sarbu I; Mitu MA; Rusu A; Gheorghe D; Petrescu S; Atkinson I; Lupuliasa D Molecules; 2022 Mar; 27(6):. PubMed ID: 35335371 [TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants. Battu SK; Repka MA; Majumdar S; Madhusudan RY Drug Dev Ind Pharm; 2007 Nov; 33(11):1225-32. PubMed ID: 18058319 [TBL] [Abstract][Full Text] [Related]
6. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets. Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060 [TBL] [Abstract][Full Text] [Related]
7. Formulation and in vivo evaluation of orally disintegrating tablets of clozapine/hydroxypropyl-β-cyclodextrin inclusion complexes. Zeng F; Wang L; Zhang W; Shi K; Zong L AAPS PharmSciTech; 2013 Jun; 14(2):854-60. PubMed ID: 23649995 [TBL] [Abstract][Full Text] [Related]
8. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex. Wang L; Zeng F; Zong L Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202 [TBL] [Abstract][Full Text] [Related]
9. A Comparative Study of Different Proportions of Superdisintegrants: Formulation and Evaluation of Orally Disintegrating Tablets of Salbutamol Sulphate. Kumar A; Saharan VA Turk J Pharm Sci; 2017 Apr; 14(1):40-48. PubMed ID: 32454593 [TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes. Desai C; Prabhakar B Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555 [TBL] [Abstract][Full Text] [Related]
11. Effect of a superdisintegrant on disintegration of orally disintegrating tablets determined by simulated wetting test and Sutthapitaksakul L; Thanawuth K; Huanbutta K; Sriamornsak P Pharmazie; 2022 Oct; 77(10):287-290. PubMed ID: 36273260 [TBL] [Abstract][Full Text] [Related]
12. Curcumin- β-Cyclodextrin Molecular Inclusion Complex: A Water-Soluble Complex in Fast-dissolving Tablets for the Treatment ofNeurodegenerative Disorders. Mugundhan SL; Balasubramaniyan P; Narayanasamy D; Mohan M Pharm Nanotechnol; 2024; 12(4):365-377. PubMed ID: 38192139 [TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression. Obaidat AA; Obaidat RM Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346 [TBL] [Abstract][Full Text] [Related]
14. Development of fast dispersible aceclofenac tablets: effect of functionality of superdisintegrants. Setty CM; Prasad DV; Gupta VR; Sa B Indian J Pharm Sci; 2008; 70(2):180-5. PubMed ID: 20046709 [TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of taste masked mouth dissolving tablets of levocetirizine hydrochloride. Sharma V; Chopra H Iran J Pharm Res; 2012; 11(2):457-63. PubMed ID: 24250469 [TBL] [Abstract][Full Text] [Related]
16. Potential use of 2-hydroxypropyl-beta-cyclodextrin for preparation of orally disintegrating tablets containing dl-alpha-tocopheryl acetate, an oily drug. Motoyama K; Nagatomo K; Abd Elazim SO; Hirayama F; Uekama K; Arima H Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1206-12. PubMed ID: 19881268 [TBL] [Abstract][Full Text] [Related]
17. Studies on the Preparation, Characterization, and Solubility of 2-HP-β-Cyclodextrin-Meclizine HCl Inclusion Complexes. George S; Vasudevan D J Young Pharm; 2012 Oct; 4(4):220-7. PubMed ID: 23493156 [TBL] [Abstract][Full Text] [Related]
18. Formulation of cyclodextrin inclusion complex-based orally disintegrating tablet of eslicarbazepine acetate for improved oral bioavailability. Desai S; Poddar A; Sawant K Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():826-34. PubMed ID: 26478377 [TBL] [Abstract][Full Text] [Related]
19. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Jug M; Bećirević-Laćan M Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex. Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]